Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
9.47
-0.14 (-1.46%)
At close: Nov 22, 2024, 4:00 PM
9.50
+0.03 (0.32%)
After-hours: Nov 22, 2024, 5:41 PM EST

Theravance Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
4665607558141,1371,470
Upgrade
Market Cap Growth
-13.49%-25.82%-7.35%-28.37%-22.63%3.64%
Upgrade
Enterprise Value
4194773201,2691,3981,620
Upgrade
Last Close Price
9.4711.2411.2211.0517.7725.89
Upgrade
PE Ratio
--0.87---
Upgrade
PS Ratio
7.329.7514.7014.7215.8220.02
Upgrade
PB Ratio
2.512.631.71-2.41-3.74-6.57
Upgrade
P/TBV Ratio
2.122.631.71---
Upgrade
EV/Sales Ratio
6.648.306.2322.9519.4622.07
Upgrade
Debt / Equity Ratio
0.240.230.12-1.98-2.23-2.28
Upgrade
Asset Turnover
0.160.120.100.130.160.15
Upgrade
Quick Ratio
4.624.8411.993.202.932.97
Upgrade
Current Ratio
4.975.3912.314.263.183.03
Upgrade
Return on Equity (ROE)
-22.88%-16.86%-179.84%---
Upgrade
Return on Assets (ROA)
-6.41%-6.73%-10.07%-35.20%-42.38%-32.49%
Upgrade
Return on Capital (ROIC)
-9.35%-8.81%-11.99%-42.23%-56.44%-45.67%
Upgrade
Earnings Yield
-10.61%-9.86%115.58%-24.49%-24.45%-16.09%
Upgrade
FCF Yield
-2.64%-5.27%-24.86%-25.94%-22.61%-16.42%
Upgrade
Buyback Yield / Dilution
18.30%24.85%-5.95%-11.41%-12.11%-3.04%
Upgrade
Total Shareholder Return
18.30%24.85%-5.95%-11.41%-12.11%-3.04%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.